AbbVie Announces Final Results of Tender Offer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises in broad rebound; yields push markets towards weekly declines
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
Goldman Sachs Remains Bullish on AbbVie (ABBV) After Meeting with Management
June 5, 2018 8:21 AM EDTGoldman Sachs reiterated a Buy rating and $135.00 price target on Abbvie (NYSE: ABBV) after meeting with management. Analyst Jami Rubin continues to believe that ABBVs hem-onc franchise remains underappreciated.
Management in particular highlighted the 1L CLL opportunity which they noted would be... More
